Literature DB >> 31498642

Pharmacophore-Directed Retrosynthesis Applied to Rameswaralide: Synthesis and Bioactivity of Sinularia Natural Product Tricyclic Cores.

Nathanyal J Truax1, Safiat Ayinde2, Khoi Van1, Jun O Liu2, Daniel Romo1.   

Abstract

A pharmacophore-directed retrosynthesis strategy applied to rameswaralide provided simplified precursors bearing the common 5,5,6 (red) and 5,5,7 (blue) skeleton present in several cembranoid and norcembranoids from Sinularia soft corals. Key steps include a Diels-Alder lactonization organocascade delivering the common 5,5,6 core and a subsequent ring expansion affording a 5,5,7 core serviceable for the synthesis of rameswaralide. Initial structure-activity relationships of intermediates en route to the natural product have revealed interesting differential and selective cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31498642      PMCID: PMC7023684          DOI: 10.1021/acs.orglett.9b02713

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  28 in total

1.  Synthetic approaches to guanacastepenes. Enantiospecific syntheses of BC and AB ring systems of guanacastepenes and rameswaralide.

Authors:  A Srikrishna; Dattatraya H Dethe
Journal:  Org Lett       Date:  2004-01-22       Impact factor: 6.005

2.  Synthesis of a Tricyclic Core of Rameswaralide.

Authors:  Barry M Trost; Hien M Nguyen; Christopher Koradin
Journal:  Tetrahedron Lett       Date:  2010-12-01       Impact factor: 2.415

3.  An efficient and general approach to beta-functionalized ketones.

Authors:  Jingliang Jiao; Larry X Nguyen; Dennis R Patterson; Robert A Flowers
Journal:  Org Lett       Date:  2007-03-03       Impact factor: 6.005

4.  Intramolecular anodic olefin coupling reactions: the effect of polarization on carbon-carbon bond formation.

Authors:  Feili Tang; Kevin D Moeller
Journal:  J Am Chem Soc       Date:  2007-09-26       Impact factor: 15.419

5.  Synthesis of a highly functionalized core of verrillin.

Authors:  Alec Saitman; Emmanuel A Theodorakis
Journal:  Org Lett       Date:  2013-04-30       Impact factor: 6.005

6.  An exploratory study of type II [3 + 4] cycloadditions between vinylcarbenoids and dienes.

Authors:  H M Davies; R L Calvo; R J Townsend; P Ren; R M Churchill
Journal:  J Org Chem       Date:  2000-07-14       Impact factor: 4.354

7.  Enantioselective Cyclopropanation of Allylic Alcohols. The Effect of Zinc Iodide.

Authors:  Scott E. Denmark; Stephen P. O'Connor
Journal:  J Org Chem       Date:  1997-05-16       Impact factor: 4.354

8.  Cyclization and ring-expansion processes involving samarium diiodide promoted reductive formation and subsequent oxidative ring opening of cyclopropanol derivatives.

Authors:  Hiroyuki Tsuchida; Mutsuko Tamura; Eietsu Hasegawa
Journal:  J Org Chem       Date:  2009-03-20       Impact factor: 4.354

9.  Highly enantio- and diastereoselective one-pot methods for the synthesis of halocyclopropyl alcohols.

Authors:  Hun Young Kim; Luca Salvi; Patrick J Carroll; Patrick J Walsh
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

10.  Simplified immunosuppressive and neuroprotective agents based on gracilin A.

Authors:  Mikail E Abbasov; Rebeca Alvariño; Christian M Chaheine; Eva Alonso; Jon A Sánchez; Michael L Conner; Amparo Alfonso; Marcel Jaspars; Luis M Botana; Daniel Romo
Journal:  Nat Chem       Date:  2019-03-22       Impact factor: 24.427

View more
  2 in total

1.  Bridging the gap between natural product synthesis and drug discovery.

Authors:  Nathanyal J Truax; Daniel Romo
Journal:  Nat Prod Rep       Date:  2020-10-26       Impact factor: 13.423

2.  Synthesis of Agelastatin A and Derivatives Premised on a Hidden Symmetry Element Leading to Analogs Displaying Anticancer Activity.

Authors:  Haoran Xue; Haleigh Svatek; Ariane F Bertonha; Keighley Reisenauer; Joshua Robinson; Minwoo Kim; Alec Ingros; Matthew Ho; Joseph Taube; Daniel Romo
Journal:  Tetrahedron       Date:  2021-07-10       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.